Diaceutics PLC Director / PDMR Shareholding
23 Maggio 2024 - 8:00AM
RNS Regulatory News
RNS Number : 5550P
Diaceutics PLC
23 May 2024
Director / PDMR Shareholding
- NED Purchase of Shares
Belfast and London, 23 May 2024 - Diaceutics PLC (AIM: DXRX) ("Diaceutics" or the "Company"), a
leading technology and solutions provider to the pharma and biotech
industry announces that on 22 May 2024, Graham Paterson, a
Non-Executive Director of Diaceutics, purchased 39,934 ordinary
shares of £0.002 each in the Company ("Ordinary Shares") at a price
of £1.2889 per Ordinary Share. As a result of the
purchase, Graham Paterson's shareholding in Diaceutics is 73,498
Ordinary Shares representing approximately 0.09% of the Company's
issued share capital.
Enquiries:
|
Diaceutics PLC
|
|
|
Ryan Keeling, Chief Executive Officer
Nick Roberts, Chief Financial
Officer
|
Tel: +44 (0)28 9040 6500
investorrelations@diaceutics.com
|
|
|
|
|
Stifel Nicolaus Europe Limited (Nomad &
Broker)
|
Tel: +44 (0)20 7710
7600
|
|
Ben Maddison
|
|
|
Nick Harland
|
|
|
Kate Hanshaw
|
|
|
|
|
|
Alma Strategic Communications
|
Tel: +44(0)20 3405
0205
|
|
Caroline Forde
|
diaceutics@almastrategic.com
|
|
|
|
About Diaceutics
At Diaceutics we believe that every
patient should get the opportunity to receive the right test and
the right therapy to positively impact their disease
outcome.
We provide the world's leading
pharma and biotech companies with an end-to-end commercialisation
solution for precision medicines through data analytics, scientific
and advisory services enabled by our platform DXRX - The
Diagnostics Network®.
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a.
|
Name
|
Graham Paterson
|
|
2
|
Reason for notification
|
|
|
a.
|
Position/Status
|
Non-Executive Director
|
|
b.
|
Initial notification/
Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
Diaceutics PLC
|
|
b.
|
LEI
|
213800VEWQBB39ZB8J81
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary shares of
£0.002 each
ISIN: GB00BJQTGV64
|
|
b.
|
Nature of the transaction
|
Purchase
|
|
c.
|
Price(s) and volume(s)
|
|
Share purchase:
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
£1.2889
|
39,934
|
|
|
|
|
d.
|
Date of the transaction
|
22 May 2024
|
|
e.
|
Place of the transaction
|
AIM Market of the London Stock
Exchange
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHQKBBNDBKBOPB
Grafico Azioni Diaceutics (LSE:DXRX)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Diaceutics (LSE:DXRX)
Storico
Da Nov 2023 a Nov 2024
